News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Daniel Drozd

Articles by Daniel Drozd

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)

ByKathryn Martin,Hope Rugo, MD,Gregory Vidal, MD, PhD,Nina Oestreicher,Deepa Lalla,Gillian Hanson,Daniel Drozd,Kristie Traverso,Dan DiPrimeo,Debu Tripathy, MD

April 18th 2022

Latest Updated Articles

24 Real-world Use of Neratinib Post-Pertuzumab (P) and –Ado-Trastuzumab Emtansine (T-DM1)
April 18th 2022

Trending on CancerNetwork

FDA Approves Brexucabtagene Autoleucel in Adult R/R MCL

Discussing a Phase 2 Defactinib/Avutometinib Trial in Diffuse Gastric Cancer

Anbenitamab Injection Combo Meets pCR End Point in HER2+ Breast Cancer

The Rise of Early-Onset Cancers: Investigating Breast and CRC Occurrences

Highlighting Emerging Genitourinary Cancer Research at Columbia University